Homocysteine and Cardiovascular Risk in Dialysis Patients

Rigatto, Claudio; Parfrey, Patrick S.

doi:10.1177/089686080002000201

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2006

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is now well-established that uremic patients have a high prevalence (84-92%) of hyperhomocysteinemia. [33][34][35][36] However, there are a few reports on comparing homocysteine levels between HD and CAPD patients. Moustapha et al [37] investigated serum homocysteine levels and the prevalence of hyperhomocysteinemia in both HD and CAPD patients.…”

Section: Discussionmentioning

confidence: 99%

Malnutrition–Inflammation–Atherosclerosis (MIA) Syndrome Components in Hemodialysis and Peritoneal Dialysis Patients

et al. 2006

View full text Add to dashboard Cite

Before choosing renal replacement therapy, malnutrition, inflammation, and atherosclerosis parameters must be investigated in ESRD patients. Hemodialysis seems to be more advantageous for malnutrition components than CAPD. Both dialysis modalities seem to be similar for inflammation, and CAPD modality has superiority for atherosclerosis. Before choosing the type of renal replacement therapy, assessment of MIA syndrome components could be useful for individualization of the decision on which dialytic modality is appropriate in ESRD patients.

show abstract